22-4-2026

CHEK2 germline pathogenic variants

Richarda de Voer is an Associate professor at the Department of Human Genetics at the Radboudumc in Nijmegen, the Netherlands.

Marleen Kets is a clinical geneticist and head of the hereditary tumour programme at the Radboudumc in Nijmegen, the Netherlands

In this webinar, we will provide a comprehensive overview of the current understanding of CHEK2 in cancer predisposition in both females and males. We will specifically address the spectrum of cancer risks, evaluate diagnostic testing strategies, and explore the unique molecular phenotypes resulting from germline variants. In addition, we will address the involvement of a range of personal and environmental modifiers in cancer risk assessment for CHEK2.

Registration: https://attendee.gotowebinar.com/register/6706466129080015965